These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
93 related items for PubMed ID: 18793742
21. [Influence of photocoagulation on the refractive index and glucose content of the aqueous humor and vitreous body]. Apponi Battini G, Sbordone G, Sbordone M, Nastri G. Minerva Oftalmol; 1968; 10(3):71-4. PubMed ID: 5745824 [No Abstract] [Full Text] [Related]
22. Origin and turnover of ECM proteins from the inner limiting membrane and vitreous body. Halfter W, Dong S, Dong A, Eller AW, Nischt R. Eye (Lond); 2008 Oct; 22(10):1207-13. PubMed ID: 18344966 [Abstract] [Full Text] [Related]
23. Two-dimensional gel electrophoresis of calf aqueous humor, serum, and filter-bound proteins. Pavao AF, Lee DA, Ethier CR, Johnson MC, Anderson PJ, Epstein DL. Invest Ophthalmol Vis Sci; 1989 Apr; 30(4):731-8. PubMed ID: 2703315 [Abstract] [Full Text] [Related]
24. [Studies of the penetrating ability of fosfomycin into the aqueous humor and vitreous body of the eye]. Philipp W, Kofler J. Klin Monbl Augenheilkd; 1986 Sep; 189(3):240-2. PubMed ID: 3784414 [Abstract] [Full Text] [Related]
25. Immunolocalization of EMMPRIN (CD147) in the human eye and detection of soluble form of EMMPRIN in ocular fluids. Määttä M, Tervahartiala T, Kaarniranta K, Tang Y, Yan L, Tuukkanen J, Sorsa T. Curr Eye Res; 2006 Nov; 31(11):917-24. PubMed ID: 17114117 [Abstract] [Full Text] [Related]
26. Human intraocular penetration pharmacokinetics of moxifloxacin 0.5% via topical and collagen shield routes of administration. Hariprasad SM, Mieler WE, Shah GK, Blinder KJ, Apte RS, Holekamp NM, Thomas MA, Chi J, Prince RA. Trans Am Ophthalmol Soc; 2004 Nov; 102():149-55; discussion 155-7. PubMed ID: 15747753 [Abstract] [Full Text] [Related]
31. Soluble Fas ligand expression in the ocular fluids of uveitis patients. Sotozono C, Sano Y, Suzuki T, Tada R, Ikeda T, Nagata S, Kinoshita S. Curr Eye Res; 2000 Jan; 20(1):54-7. PubMed ID: 10611715 [Abstract] [Full Text] [Related]
32. [Vitreous body proteins. IV. Proteolytic activity of the vitreous body in pathological conditions of the eye]. Wolańska M, Bakunowicz-Lazarczyk A. Klin Oczna; 1992 Jan; 94(2-3):44-5. PubMed ID: 1640676 [Abstract] [Full Text] [Related]
33. Integrity of the blood-aqueous barrier in hyperuricemia. Bonney CH, Lam KW, Fong D. Ann Ophthalmol; 1988 Apr; 20(4):140-2. PubMed ID: 3377384 [Abstract] [Full Text] [Related]
34. Embryonic synthesis of the inner limiting membrane and vitreous body. Halfter W, Dong S, Schurer B, Ring C, Cole GJ, Eller A. Invest Ophthalmol Vis Sci; 2005 Jun; 46(6):2202-9. PubMed ID: 15914642 [Abstract] [Full Text] [Related]
35. Proteins of the vitreous humor during experimentally induced myopia. Pickett-Seltner RL, Doughty MJ, Pasternak JJ, Sivak JG. Invest Ophthalmol Vis Sci; 1992 Nov; 33(12):3424-9. PubMed ID: 1428715 [Abstract] [Full Text] [Related]
36. The effects of experimental uveitis on anterior uveal prostaglandin transport and aqueous humor composition. Bito LZ. Invest Ophthalmol; 1974 Dec; 13(12):959-66. PubMed ID: 4609946 [No Abstract] [Full Text] [Related]
37. [Vitreous body proteins. III. Immunoelectrophoresis of the vitreous body in pathological conditions of the eye]. Wolańska M, Stankiewicz A. Klin Oczna; 1990 Jul; 92(1-2):13-4. PubMed ID: 2266689 [Abstract] [Full Text] [Related]